Intussusception Clinical Trial
Official title:
Implementation of Hospital-based Active Surveillance Procedures for Vaccine Safety Monitoring at IMSS Hospitals With Pediatric Medical Care in Mexico
This is an epidemiology study designed to implement hospital-based active surveillance for
intussusception (IS) in children <1 year of age and lower respiratory tract infection
(LRTI)-related deaths among children between 29 days and 1 year of age in Mexico. An
existing linked database of the "Instituto Mexicano del Seguro Social (IMSS)" will be used.
The study described in this protocol is a pilot study, which will evaluate the methodology
to be used in a later Post-Marketing Surveillance (PMS) study.
The planned epidemiology study will be conducted in IMSS hospitals and potentially use the
IMSS database to re-capture potential cases of IS and fatal cases and as a source of matched
case controls. The purpose of this project is to complement this data link system with an
active surveillance system for IS - in order to assess the feasibility of using the IMSS
data system by generating results that provide scientific validity. Such comprehensive
(passive and active) surveillance systems will facilitate the post licensure safety profile
evaluation of vaccines such as a vaccine against rotavirus diarrhoea.
The Protocol Posting has been updated in order to comply with the FDA Amendment Act, Sep
2007.
The main aim of this pilot study is to allow for the implementation of active hospital-based
surveillance for IS in children <1 year of age in IMSS hospitals with pediatric medical
care, and LRTI-related post-neonatal deaths among children between 29 days and 1 year of age
participating in the IMSS system. Surveillance will be conducted in each of the
approximately 230 IMSS hospitals with pediatric medical care (tertiary care and secondary
care hospitals), which have 40 million affiliates and an annual birth cohort of 575,000.
During the pilot phase the completeness and validity of electronic vaccination and
demographic data contained in the IMSS dataset will be assessed to determine whether or not
these data will be used during the actual post licensure study implementation. Study
participation for database validation will include parental/guardian/legal representative
interview and review of vaccination records.
Study staff at each of the approximately 230 IMSS hospitals will review medical records
daily for potential cases of IS in children <1 year of age.
Medical records of potential IS cases will be reviewed to determine eligibility, in terms of
IS, based on the Brighton criteria Parents/guardians/legal representative of definite IS
cases will be contacted by study staff to recruit their child into the study.
After the informed consent is signed, the parental/guardian interview will be conducted.
Additional medical information will be collected through medical record review during
hospitalization and after the child has been discharged.
A central Information Coordinator (IMSS staff member) will perform monthly reviews of the
IMSS database to search for definite IS cases.
A cross-check will be performed with IMSS database to identify definite IS cases not yet
enrolled. In that situation, parents/guardians/legal representative will be contacted by
study staff to recruit their child into the study. Either in-hospital interviews or in-home
interviews will be arranged to collect data.
Study staff will perform the same review as above but for LTRI-related deaths in children
between 29 days and 1 year of age. They will also review morgue records for LRTI-related
deaths.
A central Information Coordinator (IMSS staff member) will perform monthly reviews of the
IMSS database for post-neonatal LRTI-related deaths.
Study staff will contact the parents/guardians/legal representative of the deceased child to
explain the study and request enrollment.
After informed consent is obtained, an interview will be conducted with
parents/guardians/legal representative.
IMSS medical records will be reviewed by study staff. All LTRI related post-neonatal deaths
will be reported to the Principal Investigator (PI) and to the Safety Review Expert
Committee (SReC).
The SReC, which is completely independent from GSK Biologicals, will assign causes of death
(CoD) for all enrolled LTRI-related post-neonatal death cases.
All definite IS cases and LTRI related post-neonatal fatalities will be reported to the GSK
local operating company within 24 hours of identification. In addition all SAEs, deemed to
be related to a GSK vaccine will be reported based on discharged diagnosis only.
The completeness of key demographic data (date of birth, hospital of birth, gender, and
residential address) will be assessed for a sample of children in the IMSS dataset in a
single annual birth cohort.
A random sample (N=1,200) of children from a single annual birth cohort will be selected
from the IMSS dataset for verification of demographic data and vaccination history (the
selection process will continue until informed consent has been obtained for a total of
1,200 children). In-home interviews will be conducted with parents/guardians/legal
representative of all 1200 subjects to gather demographic and vaccination history (EPI card
- Cartilla Nacional de Vacunacion).
Demographic data collected in the interview will be compared to that in the IMSS dataset.
Vaccine history (two doses of DTP) collected from the EPI vaccination cards will be compared
to that in the IMSS dataset. The agreement for DTP will be assessed.
All IS episodes in a single annual birth cohort of children in the IMSS dataset will be
identified. Data necessary for selection of matched controls (date of birth, hospital of
birth, and gender) will be extracted for these children.
Five controls for identified IS cases will be selected from the IMSS dataset based on the
ability to fulfil the matching criteria. Statistics on the number of matched controls and
the quality of the match will be assessed by IMSS and Rixensart statisticians.
Primary outcome measure: occurrence of IS by passive (IMSS database) and active (RDE)
surveillance and of LRTI-related post-neonatal deaths by passive and active surveillance.
Secondary outcome measure: demography data of IMSS affiliate, from IMSS record and parent
interview; DTP history from IMSS dataset and EPI
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02052063 -
Does the Stapled Transanal Rectal Resection (STARR Procedure) Has an Effect on Anal Compliance ?
|
N/A | |
Completed |
NCT03185637 -
Children's Surgery in Sub-Saharan Africa
|
N/A | |
Completed |
NCT00256984 -
Study of Stapled Transanal Rectal Resection (STARR) Surgery in Refractory Constipation Associated With Obstructive Defecation Syndrome (ODS)
|
Phase 4 | |
Completed |
NCT02542462 -
Potential Mechanisms for Intussusception After Rotavirus Vaccine-Pilot Study
|
Phase 4 | |
Completed |
NCT01479491 -
Study on the Incidence of Intussusception (IS) in Children Aged < 12 Months in Japan
|
N/A | |
Completed |
NCT03360643 -
Point-of-Care Ultrasonography for Intussusception
|
N/A | |
Completed |
NCT01177839 -
Study to Assess the Incidence of Intussusception in Children < 2 Years of Age in Singapore
|
N/A | |
Completed |
NCT04020939 -
The Role of Indocyanine Green Angiography Fluorescence on Intestinal Resections in Pediatric Surgery.
|
N/A | |
Recruiting |
NCT04829032 -
GOODBYE HARTMANN TRIAL: 100 YEARS OF HARTMANN'S PROCEDURE
|
||
Completed |
NCT05259670 -
Risk Factors for Recurrent Intussusception Successful Reduction in Pediatric Patients
|
||
Not yet recruiting |
NCT04454320 -
Seasonal Variations and Different Treatment Protocols of Intussusception in Children: Our Centers Experiences
|
||
Recruiting |
NCT05710913 -
Development of Machine Learning Models for the Prediction of BMI and Complications After Bariatric Surgery (CABS-Study)
|
||
Completed |
NCT06351163 -
Minimally Invasive Surgical Management for Pediatric Intussusception: A Retrospective Cohort Study
|
||
Completed |
NCT06365333 -
Pneumatic Reduction For Intussusception In Children: A Retrospective Cohort Study
|
||
Completed |
NCT00673400 -
Stapled TransAnal Rectal Resection (STARR) With Contour® TranstarTM
|
N/A | |
Completed |
NCT04486300 -
Seasonal Variations and Different Treatment Protocols OF Intussusception In Children:
|
N/A | |
Completed |
NCT00556283 -
RCT: STARR vs Biofeedback
|
Phase 4 | |
Recruiting |
NCT05640375 -
Follow-up and Steroid Treatment Results in Intussusception
|
Phase 1/Phase 2 | |
Recruiting |
NCT02691858 -
Effect of Hydrocortisone on Improving Outcome of Pneumatic Reduction of Infantile Intussusception
|
N/A |